Comparing Fresenius SE & Co. (FSNUY) & Its Peers

Fresenius SE & Co. (OTCMKTS:FSNUY) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Fresenius SE & Co. to similar businesses based on the strength of its dividends, profitability, analyst recommendations, risk, institutional ownership, valuation and earnings.

Insider and Institutional Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Fresenius SE & Co. and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius SE & Co.	0	0	3	0	3.00
Fresenius SE & Co. Competitors	4295	10584	18370	832	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.52%. Given Fresenius SE & Co.’s competitors higher probable upside, analysts plainly believe Fresenius SE & Co. has less favorable growth aspects than its competitors.

Risk & Volatility

Fresenius SE & Co. has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Fresenius SE & Co.’s competitors have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.

Profitability

This table compares Fresenius SE & Co. and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fresenius SE & Co.	6.58%	10.24%	4.94%
Fresenius SE & Co. Competitors	-303.57%	-175.14%	-22.20%

Dividends

Fresenius SE & Co. pays an annual dividend of $0.20 per share and has a dividend yield of 1.4%. Fresenius SE & Co. pays out 25.0% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 40.5% of their earnings in the form of a dividend.

Valuation & Earnings

This table compares Fresenius SE & Co. and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Fresenius SE & Co.	$25.87 billion	$1.43 billion	18.40
Fresenius SE & Co. Competitors	$1.87 billion	$137.20 million	5.88

Fresenius SE & Co. has higher revenue and earnings than its competitors. Fresenius SE & Co. is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Fresenius SE & Co. beats its competitors on 9 of the 15 factors compared.

Fresenius SE & Co. Company Profile

Fresenius SE & Co. KGaA is a German healthcare group headquartered in Bad Homburg. Its businesses include Fresenius Kabi, which supplies medicines, clinical nutrition, infusion therapies and medical technologies, and Fresenius Helios, which operates hospitals in Germany and Spain. Fresenius Kabi serves healthcare providers around the world, while Helios focuses on hospital and healthcare services in Europe. The group traces its origins to a pharmacy in Frankfurt acquired by pharmacist Eduard Fresenius in 1912.